Search results
Q1 2024 Cerus Corp Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 3 days agoThe first quarter of 2024 was an important one in the history of the company as we reported positive top line results from the Phase III ReCePI clinical trial, the first of our 2 U.S.
Q1 2024 Emergent BioSolutions Inc Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 4 days agoWe also strengthened our relationship with key stakeholders during the quarter. Over the last three months, we've held over a dozen collaborative meetings with key stakeholders across U.S. and ...
EverGlade Consulting Welcomes New Managing Director, Joe Larsen
The Longview News-Journal· 5 days agoEverGlade Consulting is pleased to announce the appointment of Dr. Joe Larsen as Managing Director, effective April 2024. Dr. Larsen brings with him a rich background in biomedical research ...
Earnings call: Cerus Corporation sees growth with INTERCEPT RBCs trial success By Investing.com
Investing.com· 3 days agoCerus Corporation (NASDAQ:CERS) has announced positive outcomes from its Phase 3 ReCePI clinical...
Earnings call: Emergent BioSolutions raises 2024 profit outlook
Investing.com· 4 days agoEmergent BioSolutions Inc. (EBS) has provided an optimistic update during its first quarter earnings...
Launching an effective bird flu vaccine quickly could be tough, scientists warn
KPBS San Diego· 3 days agoThe bird flu that's now spreading among cows doesn't yet appear to pose an imminent threat to most...
Small Business - The Roanoke-Chowan News-Herald | The Roanoke-Chowan News-Herald
Roanoke-Chowan News-Herald· 3 days agoAllschwil, Switzerland, May 03, 2024 Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs of patients with severe bacterial and fungal infections, announced today that
